Pakistani
businessman in Guantanamo petitions court
WASHINGTON,
Mar 16: A former Pakistani businessman is
petitioning a federal appeals court over his
detention at the US prison camp at Guantanamo
Bay, Cuba, saying the mastermind of the September
11 plot and two other Al-Qaida members in US
custody can exonerate him of terrorist activity.
Saifullah Paracha,
arrested in July 2003 at the airport in Bangkok,
Thailand, said he met Osama bin Laden in
Afghanistan in 1999 and interviewed the al-Qaida
leader in 2000 for his news agency, one of seven
businesses Paracha said he owns.
Paracha says the
US Court of Appeals for the District of Columbia
Circuit should order the questioning of alleged
Al-Qaida members Majid Khan and Ammar Al-Baluchi
as well as the man who oversaw the terror attacks
of September 11, Khalid Shaikh Mohammed.
At a trial of
Paracha's son late last year, written statements
introduced from Khan and Al-Baluchi exonerate
Saifullah Paracha of any knowledge of terrorist
activities, Paracha's lawyer said in court papers
filed March 8.
Paracha's lawyer
also wants the court to order the questioning of
Mohammed, who "was intimately involved in
the contacts Khan and al-Baluchi had" with
Saifullah Paracha, the court papers added.
Paracha's son,
Uzair, 25, who says he was pressured into a false
confession, was convicted in New York in November
of trying to help Khan slip past US immigration
officials using fake travel documents to carry
out a chemical attack. (AP)

German
firm says sorry as drug trial victims fight for
life
LONDON,
Mar 16: A German drug company said it has
apologised to the families of six men who were in
hospital today, two badly deformed and fighting
for their lives, after a clinical trial in London
went horribly wrong.
Thomas Hanke,
chief scientific officer at TeGenero, also
insisted that the trial to test a medicine for
immunological diseases such as multiple
sclerosis, rheumatoid arthritis and certain
cancers had met regulatory standards.
But senior doctors
told The Times newspaper that the test at a
research unit operated by US company Parexel
International had failed to conform to best
medical practices.
Two of the six
patients were critically ill and the other four
remained in serious condition in the
intensive-care unit of Northwick Park Hospital,
an official at the north-west London hospital
said.
The men, who had
all been healthy, were admitted yesterday evening
after suddenly falling ill while taking part in
the drug trial at the independent research unit
in the hospital compound.
Doctor Hanke said
TeGenero was "devastated" at the
"shocking developments" in the testing
of its drug, which the firm identified as
TGN1412.
Asked by reporters
whether the company had apologised to the men's
families, he replied: "Yes."
Hanke also said
the drug had shown no adverse side-effects
previously and the testing had been done to
regulatory standards.
Initial research
into the new medicine started in 1997 and it had
been in development since 2000 but testing had
now been halted, Hanke added. (AFP)

US
will be able to work with UN Human Rights
Council: Annan
UNITED
NATIONS, Mar 16: The United Nations has expressed
confidence that the United States will be able to
work with the new United Nations Human Rights
Council despite its opposition to a draft
framework for the panel.
"I think in a
normal democratic process, if you can get
unanimity, well and good," UN
Secretary-General Kofi Annan said in Johannesburg
after meeting with former South African President
Nelson Mandela during a two-week visit to Africa.
"But if you
can't, and an overwhelming majority of the
members go for something, I think it should work.
"And I am
sure the US, which has done so much for human
rights, will find a way to work with the other
Member States to make the council what it ought
to be," he said.
In presenting his
proposed reforms a year ago, Annan wanted
election to be by a two-thirds majority and
failure to achieve this has been cited by the US
as one of the main elements in its opposition.
But while
conceding his inability to reach this goal, he
has repeatedly stressed that the Council as
proposed by General Assembly President Jan
Eliasson after months-long consultations with
Member States could be a basis for more effective
human rights protection.
"The
President of the General Assembly has done a
great work, working with all the member states to
come up with a document that gives a credible
basis to move forward," he said. (PTI)

No
long-term cancer risk seen from breast implants
NEW
YORK Mar 16: Results of a study that followed
women up to 30 years adds to evidence that
silicone breast implants do not boost cancer
risk.
The study, of
nearly 2,800 Danish women who received breast
implants between 1973 and 1995, found that these
women actually had a lower risk of breast cancer
than a group of similar but implant-free women.
Also, the implants were not tied to other types
of cancer, according to findings published in the
International Journal of Cancer.
Women with breast
implants did have a higher rate of non-melanoma
skin cancers, the most common and least
threatening forms of the disease. But it's
possible that greater sun exposure explains that
association, the study authors speculate.
"Our current
results support the conclusions of recent expert
review committees that silicone breast implants
are not associated with an excess risk of breast
or other cancers,'' write the researchers, led by
Dr Soren Friis of the Danish Cancer Society in
Copenhagen.
Past research had
indicated that, despite fears about the
cancer-causing potential of silicone found in
animal studies, silicone breast implants do not
lead to cancer in some women.
But few studies
had looked at breast cancer risk beyond the
15-year mark, or at the risk of tumors in sites
other than the breast, according to Friis and his
colleagues.
Women in their
study were followed for up to 30 years after
receiving breast implants, and overall, their
risk of developing breast cancer was 30 percent
lower than that of the 1,736 women in the
comparison group.
The reason for the
lower risk is unclear, according to the
researchers.
It's possible,
they speculate, that women who seek breast
implants are generally at less risk of breast
cancer; in past research, Friis's team found that
compared with other women, those with implants
tended to be thinner and have more pregnancies -
a factor that has been linked to lower breast
cancer risk.
The current study
also found no evidence that women with breast
implants were diagnosed with breast cancer any
later than other women -- even though implants
can interfere to some degree with the x-rays used
in mammography screening.
Despite their
encouraging result, the researchers advise that
''further studies of the effects of silicone
breast implants on breast cancer detection and
survival may be warranted.''
(AGENCIES)

Drop
in air pollution linked to reduced mortality
NEW
YORK, Mar 16: Reductions in fine particulate air
pollution do seem to translate into a survival
benefit on a population level, researchers have
shown.
The drop in
mortality ''was observed specifically for deaths
due to cardiovascular and respiratory disease and
not from lung cancer, a disease with a longer
latency period and less reversibility,'' Dr
Francine Laden, from Harvard Medical School in
Boston, explained in a statement.
A direct link
between death rates and small airborne particles
2.5 microns in diameter or less -- dubbed PM2.5
-- has been noted in numerous epidemiologic
studies, but it was unclear if improvements in
particle exposure would actually lead to better
survival, according to a report by Laden and her
colleagues.
As they explain in
the American Journal of Respiratory and Critical
Care Medicine, in an earlier analysis of data
from the Harvard Six Cities study, long-term
exposure to ambient PM2.5 was associated with
increased mortality.
Laden's team
analyzed data for 8 additional years of
follow-up, during a period when air pollution was
declining in many of the cities studied. The
urban areas included in the study were Watertown,
Massachusetts; Kingston and Harriman, Tennessee;
St. Louis, Missouri; Steubenville, Ohio; Portage,
Wyocena and Pardeeville, Wisconsin; and Topeka,
Kansas.
Consistent with
previous findings, the overall mortality in those
cities rose steadily with each increase in PM2.5
of 10 microgram per cubic meter. As PM2.5 levels
fell during follow-up, so did overall mortality.
The results
suggest that increases in mortality related to
PM2.5 are ''at least in part reversible,'' the
researchers conclude
(AGENCIES)
|